Secretagogue-induced pancreatitis in mice devoid of chymotrypsin

Alexandra Demcsák1, Siavash Shariatzadeh1, Miklós Sahin-Tóth1

  • 1Department of Surgery, University of California Los Angeles, Los Angeles, California, United States.

Insights

Chymotrypsin protects the pancreas from pancreatitis by degrading trypsinogen. Mice lacking chymotrypsin are healthy but develop severe pancreatitis when stimulated, highlighting chymotrypsin's crucial role in pancreas defense.

Area of Science:

  • Gastroenterology and Hepatology
  • Molecular and Cellular Biology
  • Genetics and Genomics

Background:

  • Pancreatitis is a serious inflammatory condition of the pancreas.
  • Serine proteases, like chymotrypsin, play a role in regulating digestive enzyme activation.
  • Chymotrypsin is known to degrade trypsinogen, the precursor to trypsin, potentially preventing pancreatitis.

Purpose of the Study:

  • To investigate the role of chymotrypsin in protecting the pancreas against pancreatitis.
  • To generate and characterize a novel mouse model lacking all pancreatic chymotrypsin isoforms.
  • To assess the susceptibility of chymotrypsin-deficient mice to induced pancreatitis.

Main Methods:

  • Generation of a novel mouse strain (Ctrb1-del × Ctrl-KO) lacking functional chymotrypsin genes (Ctrb1, Ctrl, and Ctrc).
  • Phenotypic analysis of the chymotrypsin-deficient mice under normal conditions.
  • Induction of acute pancreatitis using cerulein and assessment of disease severity and progression.
  • Comparison of pancreatitis development in deficient mice versus wild-type controls.

Main Results:

  • Mice devoid of chymotrypsin (Ctrb1-del × Ctrl-KO) are phenotypically normal and fertile.
  • Chymotrypsin-deficient mice exhibit significantly increased intrapancreatic trypsin activation and more severe acute pancreatitis upon cerulein stimulation.
  • These mice spontaneously progress to chronic pancreatitis, unlike wild-type mice that recover rapidly.
  • The CTRB1 isoform is the primary protector, but CTRL also contributes to pancreatic defense.

Conclusions:

  • Chymotrypsin is dispensable for normal pancreatic development and function under basal laboratory conditions.
  • Chymotrypsin is essential for preventing severe pancreatitis, particularly under conditions of secretagogue hyperstimulation.
  • The study confirms and extends the critical role of chymotrypsin in limiting pathological trypsin activity and maintaining pancreas health.